Elphis Cell Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 11

Elphis Cell Therapeutics General Information

Description

Developer of personalized cell therapies designed for vascular diseases. The company offers disease treatment utilizing complex stem cells that combine vascular endothelial progenitor cells for regenerating blood vessels and MSC, enabling healthcare professionals to address patients' symptomatic relief, including vascular bypass surgery, stents, and balloon angioplasty for mild cases.

Contact Information

Website
www.elphiscellrx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 508, 5th floor, 117-3 Hoegi-ro
  • Dongdaemun-gu, Hoegi-dong, Seoul Biohub Global Center
  • Seoul, 02455
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Digital Health, Life Sciences
Corporate Office
  • 508, 5th floor, 117-3 Hoegi-ro
  • Dongdaemun-gu, Hoegi-dong, Seoul Biohub Global Center
  • Seoul, 02455
  • South Korea
+82

Elphis Cell Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Elphis Cell Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) 23-Feb-2025 Completed Product Development
5. Accelerator/Incubator Completed Product Development
4. Early Stage VC (Series A) 11-Oct-2023 Completed Product Development
3. Accelerator/Incubator 01-Aug-2022 Completed Product Development
2. Early Stage VC (Series A) 01-Jun-2022 Completed Product Development
1. Accelerator/Incubator 01-Oct-2019 Completed Product Development
To view Elphis Cell Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Elphis Cell Therapeutics Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Elphis Cell Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026098148-A Method for producing bone marrow-derived vascular endothelial progenitor cells with enhanced angiogenesis using pdgf-bb, and method for producing a cell therapy agent for treating vascular dysplasia-related diseases using the same. Pending 26-Feb-2021

Elphis Cell Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Elphis Cell Therapeutics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nautilus Investment (South Korea) Venture Capital Minority
Nvestor (Korea) Venture Capital Minority
BSK Investment Venture Capital Minority
Daekyo Investment Corporate Venture Capital Minority
DJ & Lee Investment Partners Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Elphis Cell Therapeutics FAQs

  • When was Elphis Cell Therapeutics founded?

    Elphis Cell Therapeutics was founded in 2019.

  • Where is Elphis Cell Therapeutics headquartered?

    Elphis Cell Therapeutics is headquartered in Seoul, South Korea.

  • What is the size of Elphis Cell Therapeutics?

    Elphis Cell Therapeutics has 16 total employees.

  • What industry is Elphis Cell Therapeutics in?

    Elphis Cell Therapeutics’s primary industry is Drug Discovery.

  • Is Elphis Cell Therapeutics a private or public company?

    Elphis Cell Therapeutics is a Private company.

  • What is Elphis Cell Therapeutics’s current revenue?

    The current revenue for Elphis Cell Therapeutics is .

  • How much funding has Elphis Cell Therapeutics raised over time?

    Elphis Cell Therapeutics has raised $2.98M.

  • Who are Elphis Cell Therapeutics’s investors?

    Nautilus Investment (South Korea), Nvestor (Korea), BSK Investment, Daekyo Investment, and DJ & Lee Investment Partners are 5 of 11 investors who have invested in Elphis Cell Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process